Schedule 1 barriers to research in the UK: An in-depth qualitative analysis

Background There is increasing research to suggest that certain Schedule 1 drugs, most notably psychedelics, can be effective in treating a range of mental health disorders. However, due several practical, financial, and bureaucratic barriers, there lack large-scale trials into their efficacy. This study aimed explore the any facilitators, undertaking through examining different positions other controlled drug researchers place themselves in, impact this has on experiences. Method Semi-structured interviews were conducted with 12 participants. Eight four who conduct research. Participants recruited via purposive snowball sampling. Interview questions explored how participants’ experiences impacted by scheduling laws, they might differ from group. Results Using discourse analysis, themes identified. Three differentiated two groups ( differential burden duties, importance privileges, motivations); duties acted as barrier non-Schedule researchers, whereas better able deal higher levels motivation more privileges (facilitating research). One theme suggested solidarity between groups; others barriers research, government officials preventing changes legislation, those lacking scientific understanding being discriminatory, causing difficulties getting projects started. Conclusion Findings highlight challenges are currently facing should commission an urgent review Advisory Council Misuse Drugs make process smoother accessible. For example, reducing substances so line regulations controlling 2.